REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $45,000 | +164.7% | 27,750 | +55.2% | 0.00% | – |
Q1 2016 | $17,000 | -15.0% | 17,877 | +7.4% | 0.00% | – |
Q4 2015 | $20,000 | -74.7% | 16,643 | +50.4% | 0.00% | – |
Q2 2015 | $79,000 | -92.1% | 11,068 | -79.7% | 0.00% | – |
Q4 2013 | $996,000 | -37.8% | 54,391 | -9.0% | 0.00% | – |
Q3 2013 | $1,602,000 | -56.8% | 59,757 | -70.2% | 0.00% | -100.0% |
Q2 2013 | $3,706,000 | – | 200,805 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |